1. Home
  2. CDNA vs SDGR Comparison

CDNA vs SDGR Comparison

Compare CDNA & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

N/A

Current Price

$17.75

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

N/A

Current Price

$12.95

Market Cap

856.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDNA
SDGR
Founded
1998
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
856.7M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CDNA
SDGR
Price
$17.75
$12.95
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$27.33
$24.33
AVG Volume (30 Days)
591.0K
1.6M
Earning Date
05-13-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
$48,324,000.00
$255,869,000.00
Revenue This Year
$15.37
$6.11
Revenue Next Year
$11.23
$7.69
P/E Ratio
N/A
N/A
Revenue Growth
18.93
23.29
52 Week Low
$10.96
$11.11
52 Week High
$21.49
$27.63

Technical Indicators

Market Signals
Indicator
CDNA
SDGR
Relative Strength Index (RSI) 37.96 48.76
Support Level $16.74 $11.11
Resistance Level $18.02 $13.36
Average True Range (ATR) 0.85 0.70
MACD -0.13 0.32
Stochastic Oscillator 23.20 82.44

Price Performance

Historical Comparison
CDNA
SDGR

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Share on Social Networks: